NCT05445661 is a NA clinical trial of injectable poly-L-lactic acid in Skin Laxity, sponsored by Goldman, Butterwick, Fitzpatrick and Groff.

Who is sponsoring NCT05445661?

NCT05445661 is sponsored by Goldman, Butterwick, Fitzpatrick and Groff.

What drugs are being tested in NCT05445661?

Interventions in NCT05445661: injectable poly-L-lactic acid, Normal Saline.

What condition does NCT05445661 study?

NCT05445661 studies Skin Laxity.

Is NCT05445661 still recruiting?

NCT05445661 is currently status unknown. Last updated 6 July 2022.

Last reviewed 2022-07-06 · How we verify

NCT05445661

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Sculptra to Aid in Treatment of Arm Laxity

Status unknown NA Last updated 6 July 2022

What this trial tests

NA trial testing injectable poly-L-lactic acid in Skin Laxity in 20 participants. Status unknown.

Timeline

20 July 2022

Primary endpoint
20 September 2023

20 September 2023

Quick facts

Lead sponsor	Goldman, Butterwick, Fitzpatrick and Groff
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	20
Start date	20 July 2022
Primary completion	20 September 2023
Estimated completion	20 September 2023

Drugs / interventions tested

injectable poly-L-lactic acid — full drug profile →
Normal Saline

Conditions studied

Skin Laxity — all drugs for Skin Laxity →

Sponsor

Goldman, Butterwick, Fitzpatrick and Groff — full company profile →

Who can join

Adults 40 to 70, female only, with Skin Laxity. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To assess the safety, efficacy, and patient satisfaction associated with the treatment of upper inner arm crepiness/laxity with injectable poly-L-lactic acid (PLLA, Sculptra® Aesthetic; Galderma Laboratories; Fort Worth, TX).

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Injectable Poly-L-Lactic Acid for Body Aesthetic Treatments: An International Consensus on Evidence Assessment and Practical Recommendations.
Haddad A, Avelar L, Fabi SG, Sarubi J, et al · · 2025 · cited 4× · PMID 39592491 · DOI 10.1007/s00266-024-04499-9

Verify or expand the search:

Other trials of injectable poly-L-lactic acid

Trials testing the same drug.

NCT05269654 — Injectable Poly-L-Lactic Acid for Volumization and Adipogenesis of the Hip Dell · NA · unknown

Other recruiting trials for Skin Laxity

Currently open trials in the same condition.

NCT07224880 — Ellacor® Micro-Coring Technology® in Fitzpatrick Skin Types I-VI, Including Patients Receiving Glucagon-Like Peptide-1 R · recruiting
NCT06941610 — An Evaluation of the Erchonia Laser As a Non-Invasive Treatment to Improve the Appearance of Skin Laxity · NA · recruiting
NCT06724510 — Safety and Efficacy Evaluation of High Intensity Focused Ultrasound Device in Eyebrow Lifting · NA · recruiting
NCT06603194 — Benefit of Bovine or Marine Collagen Vs. Placebo on Skin, Hair, Nails and Whole Body Health in Healthy Adults · NA · recruiting
NCT06557434 — AV-23-001 AVAVA MIRIA Pilot Study · NA · active not recruiting

Other Goldman, Butterwick, Fitzpatrick and Groff trials

Trials by the same sponsor.

NCT07462533 — Assess Efficacy of a Nanodiamond Periprocedural Skin Care Regimen for Ablative Resurfacing · Phase 2 · not yet recruiting
NCT07421544 — Assess Injectable Hyaluronic Acid Gel for the Treatment of Volume Loss, Skin Laxity and Fine Lines · Phase 4 · not yet recruiting
NCT07342413 — Study Comparing Glycerin With 1% Lidocaine and Epinephrine Versus Glycerin With 1% Lidocaine Without Epinephrine for the · Phase 4 · not yet recruiting
NCT07221461 — Assess Impact of Microdroplet Hyaluronic Acid Filler on Skin Quality in Patients on Glucagon-like Peptide-1 Agonists · Phase 2 · not yet recruiting
NCT07217743 — Assess Impact of Poly-L-lactic Acid on GLP1 Subjects · Phase 2 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05445661 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Goldman, Butterwick, Fitzpatrick and Groff
Last refreshed: 6 July 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05445661.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing